4//SEC Filing
Davis Aaron I. 4
Accession 0000895345-24-000151
CIK 0001819133other
Filed
May 2, 8:00 PM ET
Accepted
May 3, 9:34 PM ET
Size
12.5 KB
Accession
0000895345-24-000151
Insider Transaction Report
Form 4
Davis Aaron I.
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2024-05-01$7.43/sh−75,000$557,250→ 618,524 total(indirect: See footnote) - Sale
Common Stock
2024-05-03$7.61/sh−60,000$456,600→ 483,524 total(indirect: See footnote) - Sale
Common Stock
2024-05-02$7.56/sh−75,000$567,000→ 543,524 total(indirect: See footnote)
Holdings
- 5,000(indirect: See footnote)
Common Stock
MVA Investors, LLC
10% Owner
Transactions
- Sale
Common Stock
2024-05-01$7.43/sh−75,000$557,250→ 618,524 total(indirect: See footnote) - Sale
Common Stock
2024-05-02$7.56/sh−75,000$567,000→ 543,524 total(indirect: See footnote) - Sale
Common Stock
2024-05-03$7.61/sh−60,000$456,600→ 483,524 total(indirect: See footnote)
Holdings
- 5,000(indirect: See footnote)
Common Stock
Footnotes (5)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.39 to $7.79, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]These securities are owned directly by MVA Investors, LLC ("MVA Investors"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.59, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.56 to $7.81, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F5]These securities are owned directly by Mr. Davis. Each reporting person other than Mr. Davis disclaims beneficial ownership of these securities.
Documents
Issuer
Tango Therapeutics, Inc.
CIK 0001819133
Entity typeother
Related Parties
1- filerCIK 0001465914
Filing Metadata
- Form type
- 4
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 9:34 PM ET
- Size
- 12.5 KB